2m 2m 2m 2m 2m 2m 2m
LISATA THERPTCS (LSTA)
NASDAQ
$3.45-$0.03 (-0.86%)
Price as of Jun 03, 2026 7:16 PM EDT- $29.6MMarket Cap
- 33.68%1-Year Change
- BiotechnologyIndustry
LISATA THERPTCS (LSTA)
$3.45-$0.03 (-0.86%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 170,000 -83.00% | 1.0M N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 170,000 -83.00% | 1.0M N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | 422,000 -27.49% | 582,000 -95.51% | 13.0M -8.25% | 14.1M +24.37% | |
Research and Development Expense | -7.9M -29.87% | -11.3M -10.99% | -12.7M -70.70% | -43.5M +145.81% | |
Depreciation and Amortization Expense | 146,000 -16.09% | 174,000 -7.94% | 189,000 +173.91% | 69,000 +25.45% | |
Total Operating Expenses | 18.4M -21.49% | 23.4M -8.94% | 25.7M -55.37% | 57.6M +98.28% | |
Operating Profit | -18.2M -18.74% | -22.4M -12.83% | -25.7M -55.37% | -57.6M +98.28% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 661,000 -59.35% | 1.6M -35.93% | 2.5M +182.94% | 897,000 +1,080.26% | |
Income before Taxes | -17.5M -15.57% | -20.8M -10.30% | -23.2M -59.14% | -56.7M +95.71% | |
Income Taxes | -962,000 +20.55% | -798,000 -65.75% | -2.3M -6.01% | -2.5M +64.39% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -16.6M -17.01% | -20.0M -4.10% | -20.8M -61.57% | -54.2M +97.43% | |
Net Income from Continuing Operations Applicable to Common | -17.5M -15.57% | -20.8M -10.30% | -23.2M -59.14% | -56.7M +95.71% | |
Basic EPS and Net Income | -1.91 -20.42% | -2.40 -6.98% | -2.58 -75.36% | -10.47 +1,994.00% | |
Diluted EPS and Net Income | -1.91 -20.42% | -2.40 -6.98% | -2.58 -75.36% | -10.47 +1,994.00% | |
Basic Weighted Average Shares | 8.7M +4.30% | 8.3M +3.17% | 8.1M +55.85% | 5.2M -90.64% | |
Diluted Weighted Average Shares | 8.7M +4.30% | 8.3M +3.17% | 8.1M +55.85% | 5.2M -90.64% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 16.0M -1.56% | 16.2M -28.26% | 22.6M -29.74% | 32.2M +30.46% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 16.0M -1.56% | 16.2M -28.26% | 22.6M -29.74% | 32.2M +30.46% | |
Total Current Assets | 17.7M -48.80% | 34.6M -35.88% | 53.9M -24.98% | 71.9M -25.27% | |
Accumulated Depreciation | 476,000 -19.19% | 589,000 +21.19% | 486,000 +16.55% | 417,000 +13.32% | |
Property and Plant and Equipment and Net | 18,000 -75.00% | 72,000 -58.86% | 175,000 -40.88% | 296,000 +377.42% | |
Total Long-Term Assets | 23,000 -85.62% | 160,000 -51.81% | 332,000 -37.12% | 528,000 -30.89% | |
Total Assets | 17.7M -49.31% | 35.0M -36.00% | 54.7M -25.11% | 73.0M -24.71% | |
Income Taxes Payable | N/A N/A | N/A N/A | 4.2M +11.83% | 3.7M +43.99% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 3.1M -45.29% | 5.6M -14.83% | 6.6M +3.24% | 6.4M +41.12% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 72,000 0.00% | 72,000 -65.71% | 210,000 -35.78% | 327,000 -32.58% | |
Total Liabilities | 3.1M -44.71% | 5.7M -16.40% | 6.8M +1.34% | 6.7M +33.99% | |
Retained Earnings | -564.7M +3.03% | -548.1M +3.78% | -528.1M +4.11% | -507.2M +11.97% | |
Total Stockholders Equity | 14.9M -49.76% | 29.6M -38.58% | 48.1M -27.68% | 66.6M -27.83% | |
Total Shares Outstanding | 8.8M +5.05% | 8.4M +3.18% | 8.1M +3.61% | 7.9M -86.84% | |
Cash Flow | |||||
Cash from Operating Activities | -15.9M -17.60% | -19.4M -3.37% | -20.0M -5.38% | -21.2M -4.83% | |
Capital Expenditures | 28,000 N/A | N/A N/A | 0 -100.00% | 285,000 +375.00% | |
Cash from Investing Activities | 15.1M +14.00% | 13.2M +30.99% | 10.1M -65.06% | 28.9M +152.67% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 599,000 +390.78% | -206,000 -153.51% | 385,000 +271.88% | -224,000 -100.26% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -10,711.18% +377.99% | -2,240.90% N/A | N/A N/A | N/A N/A | |
Return on Assets | -62.89% +41.13% | -44.56% +36.56% | -32.63% -48.84% | -63.78% +54.43% | |
Return on Equity | -74.67% +45.19% | -51.43% +41.56% | -36.33% -46.79% | -68.28% +55.06% | |
Revenue Growth | -83.00% N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 5.76 -6.42% | 6.16 -24.72% | 8.18 -27.33% | 11.26 -47.05% | |
Cash Ratio | 5.20 +79.92% | 2.89 -15.77% | 3.43 -31.94% | 5.04 -7.56% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow